Skip to main content
ADHERIUM LIMITED logo

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Open in API
Filings indexed 878 across all filing types
Latest filing 2026-06-01 Director's Dealing
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
Initial Director's Interest Notice - Victoria Durrans 2 pages 169.2KB
Director's Dealing Classification · 96% confidence The document is an ASX Appendix 3X “Initial Director’s Interest Notice” under Listing Rule 3.19A.1, disclosing a director’s securities interests (nil in this case). This is a personal share transaction/holding disclosure by a company director, which fits the “Director’s Dealing” category.
2026-06-01 English
Final Director's Interest Notice - Bruce McHarrie 2 pages 184.2KB
Director's Dealing Classification · 88% confidence The document is an ASX Appendix 3Z “Final Director’s Interest Notice” disclosing a director’s relevant interests and changes in shareholdings under listing rule 3.19A.3. This falls squarely under insider share transactions by a director, matching the Director’s Dealing category.
2026-06-01 English
Adherium presents first dataset from RPM channel at EAC 4 pages 510.2KB
Regulatory Filings Classification · 85% confidence The document is an ASX Release providing details of clinical dataset findings and methods rather than financial results, board changes, or any formal report (e.g., 10-K, IR). It is filed as a public regulatory announcement to the Australian Securities Exchange without substantive financial statements or investor slide decks. It does not announce a forthcoming report release only; it presents the data itself. Therefore, it best fits the ‘Regulatory Filings’ fallback category (RNS).
2026-06-01 English
Adherium appoints John Perry as Chief Commercial Officer 3 pages 176.5KB
Board/Management Information Classification · 90% confidence The document is an ASX Release announcing the appointment of John Perry as Chief Commercial Officer. It fully describes a senior management change and provides background on the executive’s experience. This fits the category of Board/Management Information (announcement of a new C-level appointment), code MANG.
2026-06-01 English
Board Renewal 2 pages 118.4KB
Board/Management Information Classification · 92% confidence The document is an ASX release titled “Board Renewal” announcing changes to the positions of Chair and Non-Executive Directors, including appointments, retirements, and committee roles. This is a clear announcement of changes in the company’s board and senior management. Therefore, it fits the Board/Management Information category (MANG).
2026-06-01 English
Adherium Investor Webinar - Revised Date 2 pages 184.7KB
Regulatory Filings Classification · 85% confidence The document is an ASX market announcement notifying investors of a rescheduled date for an upcoming investor webinar. It does not provide financial results, substantive data tables, or detailed presentation materials; rather, it is a notice of an event. It does not fit specific categories such as earnings release, interim report, or investor presentation (no slides or detailed content included). Therefore, it falls into the general regulatory announcement category (RNS).
2026-06-01 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.